0001658551-19-000003.txt : 20191231 0001658551-19-000003.hdr.sgml : 20191231 20191231112046 ACCESSION NUMBER: 0001658551-19-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191231 DATE AS OF CHANGE: 20191231 EFFECTIVENESS DATE: 20191231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658551 IRS NUMBER: 464600503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-356768 FILM NUMBER: 191318573 BUSINESS ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-683-0917 MAIL ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 D/A 1 primary_doc.xml X0708 D/A LIVE 0001658551 Amylyx Pharmaceuticals, Inc. 43 THORNDIKE STREET CAMBRIDGE MA MASSACHUSETTS 02141 617-683-0917 DELAWARE None None Corporation true 2014 Joshua Cohen 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Justin Klee 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Stephen Chubb 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Director George Milne 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Director Peter Finn c/o Rubin and Rudman LLP 53 State Street Boston MA MASSACHUSETTS 02110 Executive Officer Walter Gilbert 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Director Isaac Cheng 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Director Felix Von Coerper 43 Thorndike Street Cambridge MA MASSACHUSETTS 02141 Director Pharmaceuticals Decline to Disclose 06b true 0001658551-19-000001 2019-12-17 false true false 10000 15000000 936843 14063157 false 8 0 0 360000 true Executive Compensation false Amylyx Pharmaceuticals, Inc. Peter B. Finn Peter B. Finn Secretary 2019-12-31